Evidence map›Paper›PMID 33573710›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2021

Comparison and correlation of commercial SARS-CoV-2 real-time-PCR assays, Ireland, June 2020.

Anne Carroll, Eleanor McNamara

Abstract readComparative Study
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 - a double-blind, randomized placebo-controlled trial.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Trial
  2. RT-qPCR Testing and Performance Metrics in the COVID-19 Era.International journal of molecular sciences · 2024
    Review
  3. Testing for COVID-19: a 2023 update.Australian prescriber · 2023
    Review
  4. Article
  5. Article
  6. A pandemic guided by the SARS-CoV-2 PCR test: What should the clinician know?South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2022
    Article
  7. Article
  8. Article
  9. RT-qPCR Diagnostics: The "Drosten" SARS-CoV-2 Assay Paradigm.International journal of molecular sciences · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anne CarrollPublic Health Laboratory-Health Service Executive-Dublin, Ireland.
Eleanor McNamaraPublic Health Laboratory-Health Service Executive-Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the performance of a variety of commercially available SARS-CoV-2 PCR kits, used in several different sites across Ireland to determine if C

Indexed as

Reagent Kits, DiagnosticReal-Time Polymerase Chain ReactionCOVID-19HumansIrelandReproducibility of ResultsSARS-CoV-2Reagent Kits, DiagnosticCycle thresholdRT-PCRSARS-CoV-2

Identifiers

PMID33573710
PMCPMC7879503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.